Evelo Biosciences Inc

NASDAQ:EVLO   3:26:42 PM EDT
1.83
+0.06 (+3.39%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Evelo Biosciences Inc Stock, NASDAQ:EVLO

620 Memorial Drive, 5th floor, Cambridge, Massachusetts 02139
United States of America
Phone: +1.617.577.0300
Number of Employees: 122

Description

Evelo Biosciences, Inc. operates as a clinical stage biotechnology company, which engages in the development of orally delivered investigational medicines. Its portfolio includes EDP1066 and EDP1815 for the treatment of inflammatory diseases, EDP2939 for inflammation, and EDP1908 for oncology. The company was founded by Noubar B. Afeyan and David A. Berry in 2014 and is headquartered in Cambridge, MA.